Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding Luke Timmerman 11/09/09 Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding Luke Timmerman 10/26/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News Luke Timmerman 08/27/09 Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival Luke Timmerman 08/20/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety Luke Timmerman 08/20/09 Seattle
Zymo Gets $6M in Q2 Recothrom Sales Luke Timmerman 08/03/09 Seattle
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News Luke Timmerman 05/07/09 Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market Luke Timmerman 05/05/09 Seattle
ZymoGenetics Clamps Down on Losses, Predicts Climbing Recothrom Sales Luke Timmerman 02/11/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex Luke Timmerman 01/05/09 Seattle
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial Luke Timmerman 12/08/08 Seattle
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow Luke Timmerman 11/04/08 Seattle
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects Luke Timmerman 11/03/08 Seattle
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval Luke Timmerman 09/02/08 Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace Luke Timmerman 08/06/08 Seattle
ZymoGenetics Receives $100 Million Commitment From Deerfield Luke Timmerman 06/30/08 Seattle
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.